ZSAN - Zosano Pharma Corporation

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 549.09M
Enterprise Value 344.62M
Trailing P/E N/A
Forward P/E 1-1.29
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)2.46
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-1.23

Trading Information

Stock Price History

Beta (3Y Monthly) 3.85
52-Week Change 3-29.97%
S&P500 52-Week Change 3-0.33%
52 Week High 36.6500
52 Week Low 31.8500
50-Day Moving Average 33.0207
200-Day Moving Average 33.4683

Share Statistics

Avg Vol (3 month) 3270.31k
Avg Vol (10 day) 3227.6k
Shares Outstanding 5N/A
Float 13.79M
% Held by Insiders 11.39%
% Held by Institutions 138.03%
Shares Short (Jul 31, 2019) 41.36M
Short Ratio (Jul 31, 2019) 45.88
Short % of Float (Jul 31, 2019) 49.17%
Short % of Shares Outstanding (Jul 31, 2019) 47.67%
Shares Short (prior month Jun 28, 2019) 41.41M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 220/1
Last Split Date 3Jan 26, 2018

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-50.66%
Return on Equity (ttm)-134.70%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)-25.51M
EBITDA -36.15M
Net Income Avi to Common (ttm)-37.1M
Diluted EPS (ttm)-2.8060
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)17.74M
Total Cash Per Share (mrq)1.05
Total Debt (mrq)15.63M
Total Debt/Equity (mrq)82.25
Current Ratio (mrq)1.23
Book Value Per Share (mrq)1.13

Cash Flow Statement

Operating Cash Flow (ttm)-33.34M
Levered Free Cash Flow (ttm)-24.09M